3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine

C26H22N6 — CID 137086836

IUPAC3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine
SMILESC/C=C\C=C(\c1ccncc1)c1cc(-c2[nH]nc3ncc(-c4ccncc4)cc23)[nH]c1C
InChIInChI=1S/C26H22N6/c1-3-4-5-21(19-8-12-28-13-9-19)22-15-24(30-17(22)2)25-23-14-20(16-29-26(23)32-31-25)18-6-10-27-11-7-18/h3-16,30H,1-2H3,(H,29,31,32)/b4-3-,21-5-
InChIKeyLCCYPQYLGJHBFG-ORDHDTLESA-N
MW418.50 g/mol
LogP5.73
Rot. Bonds5

About 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine

3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine (PubChem CID 137086836) has the molecular formula C26H22N6 and a molecular weight of 418.50 g/mol. Its IUPAC name is 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine.

Molecular Properties

Compound Name3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine
PubChem CID137086836
Molecular FormulaC26H22N6
Molecular Weight418.50 g/mol
Exact Mass418.19
IUPAC Name3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine
SMILESC/C=C\C=C(\c1ccncc1)c1cc(-c2[nH]nc3ncc(-c4ccncc4)cc23)[nH]c1C
InChIInChI=1S/C26H22N6/c1-3-4-5-21(19-8-12-28-13-9-19)22-15-24(30-17(22)2)25-23-14-20(16-29-26(23)32-31-25)18-6-10-27-11-7-18/h3-16,30H,1-2H3,(H,29,31,32)/b4-3-,21-5-
InChIKeyLCCYPQYLGJHBFG-ORDHDTLESA-N
XLogP5.73
TPSA83.14 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500418.50
LogP ≤ 55.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine?
The IUPAC name of 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine (CID 137086836) is 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine.
What is the SMILES notation for 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine?
The canonical SMILES for 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine is C/C=C\C=C(\c1ccncc1)c1cc(-c2[nH]nc3ncc(-c4ccncc4)cc23)[nH]c1C.
What is the InChIKey of 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine?
The InChIKey is LCCYPQYLGJHBFG-ORDHDTLESA-N. The full InChI is InChI=1S/C26H22N6/c1-3-4-5-21(19-8-12-28-13-9-19)22-15-24(30-17(22)2)25-23-14-20(16-29-26(23)32-31-25)18-6-10-27-11-7-18/h3-16,30H,1-2H3,(H,29,31,32)/b4-3-,21-5-.
What are the key properties of 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine?
3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine has a molecular weight of 418.50 g/mol, XLogP of 5.73, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-methyl-4-[(1Z,3Z)-1-pyridin-4-ylpenta-1,3-dienyl]-1H-pyrrol-2-yl]-5-pyridin-4-yl-2H-pyrazolo[3,4-b]pyridine is sourced from PubChem (CID 137086836), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).